Article citationsMore>>

Goto, T., Takano, M., Albergaria, A., Briese, J., Pomeranz, K.M., Cloke, B., et al. (2008) Mechanism and Functional Consequences of Loss of FOXO1 Expression in Endometrioid Endometrial Cancer Cells. Oncogene, 27, 9-19.
http://dx.doi.org/10.1038/sj.onc.1210626

has been cited by the following article:

• TITLE: Evaluating the p-FOXO1/FOXO1 Ratio: An Alternative Strategy for Endometrial Cancer Diagnosis

  AUTHORS: Mohsen Korani, Soudabeh Fallah

  KEYWORDS: Endometrial Cancer, FOXO1, p-FOXO1, Transcription Factor

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.3, March 26, 2015

  ABSTRACT: Background: The FOXO subfamily of Forkhead transcription factors plays a central role in pro-moting expression of proapoptotic and cell cycle regulatory genes. FOXO1 expression has an im-portant role in human endometrium homeostasis. Therefore, reduced FOXO1 protein and its inactivation by phosphorylation might, play a role in progression of human endometrial cancer. Methods: Current study was designed to investigate the changes of the FOXO1, phosphorylated-FOXO1 (p-FOX1) proteins levels and the p-FOXO1/FOXO1 ratio in 30 patients with endometrial cancer and 20 subjects with normal endometrium, surgically using excised human endometrial tissue specimens, quantitative real time PCR and western blot methods. Results: FOXO1 protein level in patients with endometrial cancer significantly reduced in comparison with control group (0.17 ± 0.15 vs. 1 ± 0.14; p